Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Amphastar P stock
Learn how to easily invest in Amphastar P stock.
Amphastar P is a drug manufacturers-specialty & generic business based in the US. Amphastar P shares (AMPH) are listed on the NASDAQ and all prices are listed in US Dollars. Amphastar P employs 1,761 staff and has a trailing 12-month revenue of around $476.9 million.
How to buy shares in Amphastar P
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AMPH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Amphastar P stock price (NASDAQ: AMPH)Use our graph to track the performance of AMPH stocks over time.
Amphastar P shares at a glance
|Latest market close||$28.10|
|52-week range||$18.12 - $44.46|
|50-day moving average||$32.50|
|200-day moving average||$31.47|
|Wall St. target price||$40.67|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.78|
Buy Amphastar P shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Amphastar P stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Amphastar P price performance over time
|1 week (2022-09-23)||1.96%|
|1 month (2022-09-01)||-5.39%|
|3 months (2022-07-01)||-20.51%|
|6 months (2022-04-01)||-24.89%|
|1 year (2021-09-27)||45.90%|
|2 years (2020-10-01)||47.58%|
|3 years (2019-10-01)||43.00%|
|5 years (2017-09-29)||57.25%|
Is Amphastar P stock undervalued or overvalued?
Valuing Amphastar P stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amphastar P's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amphastar P's P/E ratio
Amphastar P's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Amphastar P shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Amphastar P's PEG ratio
Amphastar P's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.77. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Amphastar P's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Amphastar P's EBITDA
Amphastar P's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $120.8 million.
The EBITDA is a measure of a Amphastar P's overall financial performance and is widely used to measure a its profitability.
Amphastar P financials
|Revenue TTM||$476.9 million|
|Operating margin TTM||20.39%|
|Gross profit TTM||$199.7 million|
|Return on assets TTM||8.75%|
|Return on equity TTM||19.1%|
|Market capitalisation||$1.4 billion|
TTM: trailing 12 months
Amphastar P share dividends
We're not expecting Amphastar P to pay a dividend over the next 12 months.
Amphastar P share price volatility
Over the last 12 months, Amphastar P's shares have ranged in value from as little as $18.12 up to $44.46. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amphastar P's is 0.7339. This would suggest that Amphastar P's shares are less volatile than average (for this exchange).
Amphastar P overview
Amphastar Pharmaceuticals, Inc. , a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API.
Amphastar P in the news
7 Safe Stocks to Rely on When the Market Swerves
Here's Why We Think Amphastar Pharmaceuticals (NASDAQ:AMPH) Might Deserve Your Attention Today
Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
Frequently asked questionsWhat percentage of Amphastar P is owned by insiders or institutions?
Currently 22.239% of Amphastar P shares are held by insiders and 63.518% by institutions. How many people work for Amphastar P?
Latest data suggests 1,761 work at Amphastar P. When does the fiscal year end for Amphastar P?
Amphastar P's fiscal year ends in December. Where is Amphastar P based?
Amphastar P's address is: 11570 6th Street, Rancho Cucamonga, CA, United States, 91730 What is Amphastar P's ISIN number?
Amphastar P's international securities identification number is: US03209R1032 What is Amphastar P's CUSIP number?
Amphastar P's Committee on Uniform Securities Identification Procedures number is: 03209R103
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert